239 related articles for article (PubMed ID: 15060199)
1. Hematopoietic stem cells.
Trigg ME
Pediatrics; 2004 Apr; 113(4 Suppl):1051-7. PubMed ID: 15060199
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
[TBL] [Abstract][Full Text] [Related]
4. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
5. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Ringdén O; Remberger M; Svenberg P; Svahn BM; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Bone Marrow Transplant; 2007 Apr; 39(7):383-8. PubMed ID: 17310137
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of children with aplastic anemia.
Kurre P; Johnson FL; Deeg HJ
Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
[TBL] [Abstract][Full Text] [Related]
9. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia.
Mao P; Zhu Z; Wang H; Wang S; Mo W; Ying Y; Li Q; Xu Y
Eur J Haematol; 2005 Nov; 75(5):430-5. PubMed ID: 16191094
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
Führer M
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S97-100. PubMed ID: 18978755
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of hematopoietic growth factors.
Löwenberg B; Dale DC; Sheridan WP
Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
[No Abstract] [Full Text] [Related]
13. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
[TBL] [Abstract][Full Text] [Related]
14. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia.
Lacerda JF; Martins C; Carmo JA; Lourenço F; Juncal C; Ismail S; Lacerda JM
Biol Blood Marrow Transplant; 2005 May; 11(5):399-400. PubMed ID: 15846294
[No Abstract] [Full Text] [Related]
16. Rapid autologous marrow recovery and eradication of infectious mononucleosis despite severe immunosuppression following second transplantation for aplastic anemia.
Rossbach HC; Hosler KM; Chamizo W; Mueller T; Grana NH; Lacson AG; Barbosa JL
Bone Marrow Transplant; 1999 Jan; 23(1):91-3. PubMed ID: 10037057
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
Aversa F; Reisner Y; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
[TBL] [Abstract][Full Text] [Related]
18. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
19. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
20. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
Resnick IB; Shapira MY; Slavin S
Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
